DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 08 · Volume 123 · September 2015 DOI: 10.1055/s-005-30158

Review

441
Lindholm, J.: Problems in Interpretation of the Short Acth Test: an Update and Historical Notes

Article

445
Noh, J. M.; Shen, C.; Kim, S. J.; Kim, M. R.; Kim, S. H.; Kim, J. H.; Park, B. H.; Park, J. H.: Interleukin-1β Increases Angptl4 (FIAF) Expression via the JNK Signaling Pathway in Osteoblastic MC3T3-E1 Cells
446
Krysiak, R.; Kowalska, B.; Szkróbka, W.; Okopień, B.: The Association between Macroprolactin Levels and Vitamin D Status in Premenopausal Women with Macroprolactinemia: A Pilot Study
451
Eroglu, M.; Erbag, G.; Turkon, H.; Binnetoglu, E.; Ozkul, F.; Gunes, F.; Sen, H.; Yilmaz, Y.; Sahin, M.; Ukinc, K.; Asik, M.: Are Small Adrenal Incidentalomas Solely a Radiological Finding?
461
Ebinger, M.; Ipsen, N.; Leonards, C. O.; Empl, L.; Hanne, L.; Liman, T.; Mai, K.; Strasburger, C. J.; Spranger, J.; Endres, M.: Circulating Insulin-like Growth Factor Binding Protein-3 Predicts One-year Outcome after Ischemic Stroke
466
Tsioga, M. N.; Oikonomou, D.; Vittas, S.; Kalscheuer, H.; Roeder, E.; Wintgens, K. F.; Nawroth, P. P.; Wolfrum, C.; Rudofsky, G.: Plasma Myostatin is only a Weak Predictor for Weight Maintenance in Obese Adults
473
Cataldo, L. R.; Cortés, V. A.; Mizgier, M. L.; Aranda, E.; Mezzano, D.; Olmos, P.; Galgani, J. E.; Suazo, J.; Santos, J. L.: Fluoxetine Impairs Insulin Secretion without Modifying Extracellular Serotonin Levels in MIN6 β-cells
479
Cavusoglu, T.; Karadeniz, T.; Cagiltay, E.; Karadeniz, M.; Yigitturk, G.; Acikgoz, E.; Uyanikgil, Y.; Ates, U.; Tuglu, M. İ.; Erbas, O.: The Protective Effect of Losartan on Diabetic Neuropathy in a Diabetic Rat Model
485
Campero, M.; Ezquer, M.; Ezquer, F.: Nerve Excitability and Structural Changes in Myelinated Axons from Diabetic Mice
492
Goto, T.; Nakayama, R.; Yamanaka, M.; Takata, M.; Takazawa, T.; Watanabe, K.; Maruta, K.; Nagata, R.; Nagamine, J.; Tsuchida, A.; Kato, H.: Effects of DSP-8658, a Novel Selective Peroxisome Proliferator-activated Receptors a/γ Modulator, on Adipogenesis and Glucose Metabolism in Diabetic Obese Mice
Supplementary Material
500
Ghadge, A.; Harke, S.; Khadke, S.; Diwan, A.; Pankaj, M.; Kulkarni, O.; Ranjekar, P.; Harsulkar, A.; Kuvalekar, A. A.: Effects of Commonly Used Antidiabetic Drugs on Antioxidant Enzymes and Liver Function Test Markers in Type 2 Diabetes Mellitus Subjects – Pilot Study
508
Qi, S.-d.; He, Z.-l.; Chen, Y.; Ma, J.; Yu, W.-h.; Li, Y.-y.; Yang, F.-m.; Wang, J.-b.; Chen, L.-x.; Zhao, Y.; Lu, S.-y.: Relevance and Clinical Significance of Serum Resistin Level in Obese T2DM Rhesus Monkey Models